Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
01:00pm, Friday, 25'th Apr 2025
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Boston Scientific (BSX) is a Strong Momentum Stock
10:50am, Friday, 25'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
10:46am, Friday, 25'th Apr 2025
Here is how Boston Scientific (BSX) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints
03:41pm, Thursday, 24'th Apr 2025
Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO , April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today an
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results
02:13pm, Thursday, 24'th Apr 2025
Boston Scientific Corporation BSX posted better-than-expected earnings for the first quarter on Wednesday.
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
10:45am, Thursday, 24'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript
11:34am, Wednesday, 23'rd Apr 2025
Boston Scientific Corporation (NYSE:BSX ) Q1 2025 Results Conference Call April 23, 2025 8:00 AM ET Company Participants Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman
BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised
10:50am, Wednesday, 23'rd Apr 2025
Boston Scientific's first-quarter 2025 performance benefits from the strength of its product portfolio.
Boston Scientific (BSX) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 23'rd Apr 2025
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street
Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition
10:22am, Wednesday, 23'rd Apr 2025
Boston Scientific Corporation BSX on Wednesday reported first-quarter 2025 revenues of $4.66 billion, beating the consensus estimate of $4.57 billion.
Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire
09:56am, Wednesday, 23'rd Apr 2025
Shares of Boston Scientific (BSX) rose sharply Wednesday after the firm posted first-quarter results that topped analysts' estimates.
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
08:40am, Wednesday, 23'rd Apr 2025
Boston Scientific (BSX) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.56 per share a year ago.
Boston Scientific raises 2025 profit forecast on strong heart device sales
08:11am, Wednesday, 23'rd Apr 2025
Boston Scientific raised its annual profit forecast after strong sales of its heart devices helped beat Wall Street expectations for first-quarter profit.
MARLBOROUGH, Mass. , April 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that Dan Brennan, executive vice president and chief financial officer, has elected to ret
Boston Scientific announces results for first quarter 2025
06:30am, Wednesday, 23'rd Apr 2025
MARLBOROUGH, Mass. , April 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.663 billion during the first quarter of 2025, growing 20.9 percent on a reported
